SELLAS Life Sciences 10K 2018 Annual report | SLS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: ABRAXANE, absolute, allele, amplification, ancillary, apportionment, arbitration, arose, atezolizumab, autoimmune, basin, BCF, bifurcate, bifurcation, biostatistical, budget, BVI, carrier, characteristic, CHMP, circumstance, circumvented, classic, clock, closure, conceived, Conditionally, conjugate, contrasted, coordinating, coordination, CTA, Cut, DACOGEN, DAURISMO, deeper, dehydrogenase, dental, description, discharge, distantly, DLT, EBMT, embedded, engineering, exploratory, facilitate, faulty, fluid, forecast, forgiven, freestanding, furlough, gemtuzumab, graphic, harmonization, helper, highest, hinder, hypomethylating, IDH, implanted, inhaled, instilled, instrument, IQVIA, isocitrate, kinase, Latin, leadership, leaflet, left, lymphoma, Marker, metabolizable, methodology, microsatelite, mistake, mITT, modest, morphological, MRI, MRP, multiplied, narrative, neurodegenerative, noncancelable, nonemployee, Northern, NPS, obligatory, ODOMZO, officially, oil, Otsuka, output, ozogamicin, pendency, permanent, PET, PIPE, Pune, punitive, puttable, QUAZAR, rationalization, reassessing, reconciling, refiled, refined, reproductive, resale, satisfactorily, SCLC, SDNY, shut, shutdown, sis, sixty, SLSG, somatic, SOX, standing, startup, Stemline, Street, synthetic, TECENTRIQ, thrombocytopenia, TIBSOVO, trillion, unanimously, undergone, understood, VENCLEXTA, venetoclax, Veterinary, XOSPATA

Removed: ABIC, abnormally, accrue, afford, Affordability, agrylin, allocate, alpha, amortization, ANDA, appointed, approximated, Ashton, assume, ATM, Australian, Avastin, bacteria, behavioral, belotecan, bevacizumab, bioavailability, bodily, book, CA, Canyon, capitalization, carcinoid, cardiac, catumaxomab, certification, Chairman, chapter, closed, compensatory, complied, concentration, confirmation, confirming, consecutive, contact, contemplate, Crow, cure, debulked, delinquent, desired, diet, discrete, Dong, duly, efficient, electronically, elevated, Eli, Employer, enforceable, Epidemiology, erosion, extension, farletuzumab, filer, formula, greatly, guaranty, gynecological, harmful, harnessing, Helicobacter, hematology, hydorxyurea, hydrochloride, hypothesized, identification, inducing, interacting, Interactive, interferon, intestinal, invalidity, ion, IR, Israel, junction, Kwang, learned, lifetime, Lincoln, live, loan, long, losing, mark, misuse, moiety, molecule, momelotinib, Monoclonal, myeloproliferative, myleoproliferative, neuvax, node, opt, outset, oversee, overseen, Page, Park, participant, pazopanib, pegylated, pharmacological, platelet, platinum, posted, precisely, predominantly, preventing, prudent, pylori, Ramon, rating, reallocation, reclassify, recombinant, Reddy, refusal, refusing, region, reliability, removal, Republic, resolved, revised, San, Schwartz, seasoned, SEER, shell, social, South, Stephen, stomach, stromal, subpoenaed, suffering, Suite, supplement, surgically, suspending, TapImmune, telephone, Teva, thereunder, thereunto, thrombocythemia, tissue, trabectedin, treasury, typical, unaudited, undersigned, WASHINGTON, Web, zip

SELLAS Life Sciences (SLS) 10-K2018 FY Annual report

Content analysis